199.05USD+1.57%Mkt Cap: 140.88B $P/E: 38.65Today
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, L…
Industry Peers
Diagnostics & Research$195.86BUSDP/E 28.9
$46.71BUSDP/E 45.1
$44.46BUSDP/E 41.5
$38.66BUSD
$37.93BUSDP/E 27.0
$36.96BUSDP/E 48.0
$34.69BUSDP/E 25.8
$28.78BUSDP/E 34.6
$26.19BUSDP/E 30.4
$22.96BUSDP/E 22.9
$22.70BUSDP/E 24.5
$21.22BUSD
$15.37BUSDP/E 33.9
$12.97BUSDP/E 27.0
$12.53BUSDP/E 54.0
$11.24BUSD
$9.01BUSDP/E 21.0
$5.83BUSDP/E 234.8
$5.64BUSD
$5.25BUSDP/E 44.9
$5.16BUSD
$4.55BUSDP/E 52.8
$3.70BUSDP/E 26.1
$3.37BUSD
$3.09BUSD
$1.95BUSD
$1.84BUSD
$1.54BUSDP/E 39.0
$1.55BUSDP/E 23.5
$1.47BUSD
$1.47BUSD
$1.01BUSDP/E 21.1
$1.02BUSD
$719.43MUSD
$655.97MUSDP/E 42.7
$583.63MUSD
$550.63MUSD
$297.91MUSDP/E 3.0
$288.48MUSD
$221.82MUSD
$164.03MUSD
$140.36MUSD
$107.51MUSD
$97.25MUSD
$89.37MUSDP/E 17.2
$76.80MUSD
$61.29MUSD
$42.54MUSD
$29.48MUSD
$26.61MUSD
$22.25MUSD
$17.72MUSD
$12.71MUSD
$9.88MUSD
$8.70MUSD
$7.73MUSD
$8.04MUSD
$7.13MUSD
$6.48MUSD
$6.44MUSD
$4.66MUSD
$4.82MUSD
$3.86MUSDP/E 2.8
$3.59MUSD
$3.29MUSD
$2.79MUSD
$2.17MUSD
$1.07MUSD
$314.2KUSDP/E Infinity
$5.6KUSD
Indicators:|
Key Statistics
Company
Market Cap140.88B $
Enterprise Value152.70B $
Revenue (TTM)24.78B $
Gross Profit14.52B $
Net Income (TTM)3.61B $
Revenue/Share34.87 USD
Last Price199.05 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)38.65
P/E (Forward)21.28
PEG1.22
EV/EBITDA19.24
EV/Revenue6.16
P/S5.60
P/B2.62
EPS (TTM)5.29
EPS (Forward)9.21
52W Range
160.9347% of range242.80
52W High242.80 USD
52W Low160.93 USD
Profitability
Gross Margin59.11%
Oper. Margin22.94%
EBITDA Margin32.02%
Profit Margin14.71%
ROE6.88%
ROA4.33%
Growth
Revenue Growth3.70%
Earnings Growth9.80%
Cash Flow & Leverage
Operating CF6.42B $
CapEx (TTM)1.16B $
FCF Margin18.44%
FCF Yield3.24%
Net Debt13.98B $
Net Debt/EBITDA1.76
Balance Sheet
Debt/Equity0.37
Current Ratio1.87
Quick Ratio1.40
Book Value/Sh74.82 USD
Cash/Share8.055 USD
Dividends
Fwd Div Rate1.600 USD
Trail. Div Rate1.360 USD
Div. Yield0.84%
5Y Avg Yield0.44%
Payout Ratio26.36%
Ex-Div DateJun 26, 2026
Pay DateJul 31, 2026
Splits
Last Split1128:1000
Split DateOct 2, 2023
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)242.26 USD
Upside (mean)+21.7%
Target Range200.00 USD – 310.00 USD
$200.00+21.7% to mean$310.00
# Analysts23
Ownership
Shares Out.707.77M
Float630.64M
Insiders10.73%
Institutions84.49%
Short Interest
Short Ratio2.7d
Short % Float1.82%
Short % Out.1.62%
Shares Short11.49M
Short (prev mo.)8.40M
Technical
SMA 50179.76 (+10.7%)
SMA 200204.00 (-2.4%)
Beta0.82
S&P 52W Chg20.11%
Avg Vol (30d)3.00M
Avg Vol (10d)4.08M
Technical Indicators
RSI (14)63.5
MACD4.4032
MACD Signal3.7664
MACD Hist.+0.6369
BB Upper203.43 USD
BB Middle188.11 USD
BB Lower172.79 USD
BB Width16.29%
ATR (14)5.401 USD
Vol Ratio (20d)1.33x